Abstract

Automated approaches may allow for fast, reproducible clinical assessment of cardiovascular diseases from MRI. To develop an MRI-based deep learning (DL) disease classification algorithm to distinguish among normal subjects (NORM), patients with dilated cardiomyopathy (DCM), hypertrophic cardiomyopathy (HCM), and ischemic heart disease (IHD). Retrospective. A total of 1337 subjects (55% female), comprising normal subjects (N = 568), and patients with DCM (N = 151), HCM (N = 177), and IHD (N = 441). Balanced steady-state free precession cine sequence at 1.5/3.0 T. Bi-ventricular morphological and functional features and global and segmental left ventricular strain features were automatically extracted from short- and long-axis cine images. Variational autoencoder models were trained on the extracted features and compared against consensus disease label provided by two expert readers (13 and 14 years of experience). Adding unlabeled, normal data to the training was explored to increase specificity of NORM class. Tenfold cross-validation for model development; mean, standard deviation (SD) for measurements; classification metrics: area under the curve (AUC), confusion matrix, accuracy, specificity, precision, recall; 95% confidence intervals; Mann-Whitney U test for significance. AUCs of 0.952 for NORM, 0.881 for DCM, 0.908 for HCM, and 0.856 for IHD and overall accuracy of 0.778 were obtained, with specificity of 0.908 for the NORM class using both SAX and LAX features. Longitudinal strain features slightly improved classification metrics by 0.001 to 0.03 points, except for HCM-AUC. Differences in accuracy, metrics for NORM class and HCM-AUC were statistically significant. Cotraining using unlabeled data increased the specificity for the NORM class to 0.961. Cardiac function features automatically extracted from cine MRI have potential to be used for disease classification, especially for normal-abnormal classification. Feature analyses showed that strain features were important for disease labeling. Cotraining using unlabeled data may help to increase specificity for normal-abnormal classification. 3 TECHNICAL EFFICACY: Stage 1.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.